Skip to main content
Glama

uooks

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "drug"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, openWorld, and idempotent hints, and the description adds substantial behavioral detail: internal cascading through multiple lookup endpoints, graceful degradation when GLEIF/OpenFIGI is unavailable, ambiguous matches returning figi_candidates, explicit unresolved identifiers, and ISIN-to-LEI resolution. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but information-dense, and it front-loads the core directive and examples before diving into per-type identifier details. Each clause earns its place given the complexity of the tool, though some parenthetical passages are dense and could be split for readability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Even without an output schema, the description covers what identifiers are returned per type, how ambiguous results are surfaced, how unresolved identifiers are handled, and how failures degrade. An agent has enough context to call the tool correctly for either supported entity type.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema already covers both parameters with descriptions, and the tool description adds significant meaning: it explains ticker-vs-name lookup behavior, non-equity instrument resolution, exact issuer formatting like 'NEW YORK ST DORM AUTH' instead of the full noun phrase, and concrete drug examples. This helps avoid real misuse cases that schema alone would not prevent.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: resolve a user-spoken name to canonical/official identifiers required by other tools. It names two supported entity types and the identifier systems per type, and it clearly distinguishes this tool from siblings by positioning it as the ID-resolution step an agent should use first.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use FIRST whenever you have a name but need an ID,' which gives a clear trigger. It also provides detailed passing rules: ticker, CIK, ISIN, exact issuer formatting, avoiding full noun phrases, and brand vs generic drug names. It does not name explicit sibling alternatives to avoid, but the context is otherwise strong.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All uooks toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation3/5

Several tool families overlap at the boundaries: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route questions to the same 5,724 tools, and ask_pipeworx_beta is currently functionally identical to ask_pipeworx. The Polymarket family is large but each member has a fairly distinct role (research vs. edge scan vs. fill risk vs. tracking); the memory trio and book tools are clear.

Naming Consistency3/5

Most tools follow a snake_case verb_noun pattern (get_book, create, search_books, resolve_entity, list_subscriptions), but there are notable exceptions: recall/remember/forget are bare verbs without a domain prefix, ask_pipeworx begins with a verb but doesn't follow the noun-object structure, and ai_visibility_check/generate_llms_txt break the pattern. It's readable and mostly predictable, but not uniform.

Tool Count3/5

35 tools is heavy and exceeds the typical well-scoped range, but the server is a meta-platform exposing a universal data router plus prediction-market analysis, book lookup, memory, subscriptions, and several composite research tools. Each tool appears to earn its place, though the set feels sprawling and would benefit from consolidation of the ask_pipeworx variants.

Completeness4/5

Coverage is thorough within the apparent domains: data lookup has multiple tiers (casual, grounded, deep research, claim validation), the Polymarket workflow is complete from research to edge discovery to fill-risk verification, memory has save/retrieve/delete, and subscriptions have create/list/cancel/pull. Minor gaps exist (e.g., book author search by name only via Open Library key, no direct tool for invoking a specific raw data pack), but nothing that would strand an agent.

Resources